Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03986814 · ClinicalTrials.gov registry record
Environmental Health Effects on Your Physiology
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 92
- Enrollment target
NCT03986814: Completed study, sponsored by University of Colorado, Boulder.
NCT03986814 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03986814 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
This study evaluates the associations between exposure to air pollutants, green space, and the gut microbiome and metabolome.
Primary Outcome
16S rRNA and Shotgun Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-07-18 |
| Est. Completion | 2022-02-13 |
What the finished NCT03986814 record still lists
NCT03986814 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03986814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03986814 about?
NCT03986814 is a clinical study titled "Environmental Health Effects on Your Physiology". This study evaluates the associations between exposure to air pollutants, green space, and the gut microbiome and metabolome.
What is the current status of trial NCT03986814?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2019-07-18. Estimated completion is 2022-02-13.
Who is sponsoring clinical trial NCT03986814?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI